Last Price$112.9(4.5%)
Market Cap$13.8B
LTM Enterprise Value
$15.8B
5Y avg
$18.2B
Medical - Diagnostics & Research industry
median
$160.9M
Stock quality & Intrinsic value
7/10
0.1% undervalued
Revvity, Inc. Enterprise Value
Annual
Quarterly
LTM
Crunching data... Almost there!
| Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Enterprise Value | $3,159.7M | $2,764.3M | $3,186.1M | $1,953.1M | $2,836.2M | $3,454.8M | $2,519.4M | $4,331.1M | $5,460.7M | $5,614.2M | $6,875.3M | $6,539.1M | $8,472.0M | $10.3B | $12.8B | $17.5B | $30.0B | $21.9B | $16.1B | $15.8B |
Overvalued or undervalued?
Check the intrinsic value for RVTY
and see if it's the right time to invest.
Revvity, Inc. (RVTY) Enterprise Value comparison analysis
General
LTM Enterprise Value
OTHER METRICS
Company name
Revenue growth
EPS growth
Net Income margin
Revvity, Inc.RVTY
$15.9B
0.2%
(58.6%)
9.8%
Median Peer Set
$30.8B
2.1%
4.0%
15.6%
Thermo Fisher Scientific Inc.TMO
$223.2B
0.1%
6.8%
14.8%
Danaher CorporationDHR
$162.7B
(0.1%)
(17.9%)
16.3%
Agilent Technologies, Inc.A
$36.4B
(4.7%)
5.2%
19.8%
IDEXX Laboratories, Inc.IDXX
$35.5B
6.5%
6.1%
22.8%
IQVIA Holdings Inc.IQV
$32.9B
2.8%
2.4%
8.9%
Mettler-Toledo International Inc.MTD
$28.6B
2.2%
12.7%
22.3%
Quest Diagnostics IncorporatedDGX
$25.3B
6.7%
2.8%
8.8%
Waters CorporationWAT
$24.3B
0.1%
(1.1%)
21.6%
ICON Public Limited CompanyICLR
$17.5B
2.0%
28.7%
9.6%
Natera, Inc.NTRA
$17.2B
56.7%
(59.5%)
(11.2%)
RVTY key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 1,473.8 (12.6%) | 1,546.4 4.9% | 1,787.3 15.6% | 1,937.5 8.4% | 1,812.2 (6.5%) | 1,704.3 (6.0%) | 1,921.3 12.7% | 2,115.2 10.1% | 2,166.2 2.4% | 2,237.2 3.3% | 2,262.4 1.1% | 2,115.5 (6.5%) | 2,257.0 6.7% | 2,778.0 23.1% | 2,883.7 3.8% | 3,782.7 31.2% | 5,067.2 34.0% | 3,311.8 (34.6%) | 2,750.6 (16.9%) | 2,755.0 0.2% |
| Cost of Goods Sold (COGS) | 859.3 | 918.3 | 1,062.6 | 1,107.4 | 1,032.4 | 945.7 | 1,070.7 | 1,152.0 | 1,189.3 | 1,232.6 | 1,237.9 | 1,102.2 | 1,184.0 | 1,437.1 | 1,487.6 | 1,672.9 | 2,215.9 | 1,322.0 | 1,210.9 | 1,217.4 |
% margin | 614.5 41.7% | 628.1 40.6% | 724.7 40.5% | 830.1 42.8% | 779.8 43.0% | 758.6 44.5% | 850.6 44.3% | 963.2 45.5% | 977.0 45.1% | 1,004.6 44.9% | 1,024.5 45.3% | 1,013.4 47.9% | 1,073.0 47.5% | 1,340.9 48.3% | 1,396.1 48.4% | 2,109.9 55.8% | 2,851.3 56.3% | 1,989.8 60.1% | 1,539.7 56.0% | 1,537.7 55.8% |
| Operating Expenses | 451.3 | 478.3 | 540.7 | 630.9 | 612.0 | 586.1 | 744.4 | 765.4 | 718.9 | 780.5 | 724.8 | 725.2 | 755.6 | 1,005.9 | 1,004.7 | 1,123.3 | 1,502.5 | 1,247.1 | 1,239.1 | 1,190.9 |
| Research & Development Expenses (R&D) | 87.4 | 99.7 | 111.6 | 108.1 | 107.3 | 95.4 | 115.8 | 132.6 | 133.0 | 121.1 | 125.9 | 124.3 | 139.4 | 194.0 | 189.3 | 205.4 | 275.0 | 221.6 | 216.6 | 196.8 |
| Selling, General & Administrative Expenses (SG&A) | 365.5 | 376.8 | 444.4 | 522.9 | 504.7 | 490.7 | 628.6 | 632.7 | 585.9 | 659.3 | 598.8 | 600.9 | 616.2 | 811.9 | 815.3 | 917.9 | 1,227.5 | 1,025.5 | 1,022.6 | 994.1 |
% margin | 234.3 15.9% | 153.4 9.9% | 168.2 9.4% | 193.0 10.0% | 147.6 8.1% | 153.6 9.0% | 89.7 4.7% | 195.7 9.3% | 217.4 10.0% | 210.7 9.4% | 286.1 12.6% | 283.1 13.4% | 304.8 13.5% | 323.9 11.7% | 362.0 12.6% | 978.6 25.9% | 1,332.4 26.3% | 742.7 22.4% | 300.6 10.9% | 346.7 12.6% |
| Interest Income | 0.0 | 0.0 | 0.0 | 4.0 | 1.0 | 0.8 | 1.9 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 2.6 | 1.1 | 1.5 | 1.0 | 2.2 | 3.6 | 72.1 | 73.2 |
| Interest Expense | 0.0 | 0.0 | 41.7 | 82.1 | 17.2 | 15.9 | 24.8 | 45.8 | 49.9 | 36.3 | 38.0 | 41.5 | 43.9 | 67.0 | 63.6 | 49.7 | 102.1 | 104.0 | 98.8 | 96.3 |
| Pre-tax Income | 66.7 | 150.7 | 151.3 | 147.4 | 130.7 | 162.0 | 62.9 | 50.6 | 153.3 | 169.6 | 244.0 | 244.1 | 296.7 | 257.7 | 237.1 | 906.4 | 1,279.9 | 651.8 | 183.0 | 316.1 |
% effective tax rate | 0.1 0.2% | 32.4 21.5% | 17.5 11.5% | 21.2 14.4% | 37.9 29.0% | 26.1 16.1% | 62.8 99.7% | (17.9) (35.3%) | (12.2) (8.0%) | 8.4 5.0% | 31.3 12.8% | 28.4 11.6% | 139.8 47.1% | 20.2 7.8% | 9.4 4.0% | 178.3 19.7% | 347.6 27.2% | 129.2 19.8% | 3.5 1.9% | 33.1 10.5% |
% margin | 66.5 4.5% | 119.6 7.7% | 131.7 7.4% | 126.4 6.5% | 85.6 4.7% | 135.9 8.0% | 0.2 0.0% | 69.9 3.3% | 167.2 7.7% | 157.8 7.1% | 212.4 9.4% | 234.3 11.1% | 156.9 7.0% | 237.9 8.6% | 227.6 7.9% | 727.9 19.2% | 943.2 18.6% | 569.2 17.2% | 693.1 25.2% | 270.4 9.8% |
| EPS | 0.51 | 0.96 | 1.11 | 1.07 | 0.74 | 1.16 | 0.00 | 0.61 | 1.49 | 1.40 | 1.89 | 2.14 | 1.43 | 2.15 | 2.05 | 6.53 | 8.12 | 4.51 | 5.56 | 2.30 |
| Diluted EPS | 0.51 | 0.95 | 1.09 | 1.07 | 0.73 | 1.15 | 0.00 | 0.61 | 1.47 | 1.39 | 1.87 | 2.12 | 1.42 | 2.13 | 2.04 | 6.49 | 8.08 | 4.50 | 5.55 | 2.20 |
% margin | 287.6 19.5% | 219.2 14.2% | 264.9 14.8% | 262.6 13.6% | 200.9 11.1% | 267.0 15.7% | 200.1 10.4% | 223.2 10.6% | 331.7 15.3% | 322.6 14.4% | 378.6 16.7% | 406.0 19.2% | 424.6 18.8% | 518.8 18.7% | 609.6 21.1% | 1,202.6 31.8% | 1,726.6 34.1% | 1,300.2 39.3% | 713.6 25.9% | 848.0 30.8% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is Revvity, Inc.'s Enterprise Value?
As of today, Revvity, Inc.'s last 12-month Enterprise Value is $15.8B, based on the financial report for Dec 27, 2024 (Q4’2024).
2) What is Revvity, Inc.'s Enterprise Value growth rate?
Over the last year, Revvity, Inc.'s Enterprise Value growth was (1.5%). The average annual Enterprise Value growth rates for Revvity, Inc. have been (6.3%) over the past three years, 4.4% over the past five years.
3) Is Revvity, Inc.'s Enterprise Value growth rate Good?
Over the last year, Revvity, Inc.'s Enterprise Value growth was (1.5%), which is lower than industry growth of (0.2%). It indicates that Revvity, Inc.'s Enterprise Value growth is Bad.